Although complementary and alternative medicine (CAM) is used by many sufferers of headache/migraine, the use of CAM specifically for the treatment of headache/migraine is relatively low in the US, a recent study found. This secondary analysis of data from the 2012 US NHIS examined the use of CAM among migraine/headache sufferers, including the main reasons related to CAM use. The sample of 34,525 adults included 6,558 (18.7%) headache/migraine sufferers. Researchers found:
- Of the headache/migraine sufferers, a substantial proportion (37.6%, n=2,427) used CAM for various conditions; however, CAM use specifically for headache/migraine was much less prevalent (3.3%, n=216).
- Of those who used CAM for headache/migraine, about half used CAM in conjunction with prescription (47.8%, n=100) or over-the-counter medication (55.1%, n=113).
- The most frequently used CAM modality among all headache/migraine sufferers (n=6,558) was manipulative therapy (22.0%, n=1,317), herbal supplementation (21.7%, n=1,389) and mind-body therapy (17.9%, n=1,100).
- The top 3 reasons for using CAM for headache were general wellness (28.7%, n=60/209), improving overall health (26.8%, n=56/209), and reducing stress (16.7%, n = 35/209).
Zhang Y, Dennis JA, Leach MJ, et al. Complementary and alternative medicine use among US adults with headache or migraine: Results from the 2012 National Health Interview Survey. [Published online ahead of print July 25, 2017]. Headache. doi:10.1111/head.13148.
This Week's Must Reads
MS Risk Factors Contribute to Onset Heterogeneity, Mult Scler Relat Disord; ePub 2018 Dec 3; Briggs, et al
Severe Fatigue in MS Predicts EDSS Worsening, Mult Scler; ePub 2018 Dec 3; Vaughn, et al
Cerebrospinal Fluid Biomarkers and MS Severity, Mult Scler Relat Disord; ePub 2018 Dec 5; Masvekar, et al
Research-to-Practice Gaps in Multiple Sclerosis, Int J MS Care; ePub 2018 Nov 27; Walker, et al
Head Trauma, Autoimmune Diseases: No Link with MS , Neuroepidemiol; ePub 2018 Nov 26; Abdollahpour, et al
Must Reads in Headache & Migraine
FDA Approves Ajovy for Migraine in Adults, Teva Pharmaceutical news release; 2018 Sep 14
Headache Patients Seek High Level of Outpatient Care , Headache; ePub 2018 Jul 19; Brilla, Woo, et al
Prevalence of Optic Nerve Head Edema in the ED, Neurology; ePub 2018 Jan 5; Sachdeva, et al
Association Between Migraine and Suicidal Behavior, Headache; ePub 2017 Nov 29; Friedman, Zhong, et al
Features of SAH Headache Are Distinct from Others, Headache; ePub 2017 Nov 4; Mac Grory, et al